CalciMedica (CALC) Cash & Current Investments (2019 - 2026)

CalciMedica (CALC) has 8 years of Cash & Current Investments data on file, last reported at $8.2 million in Q1 2026.

• Quarterly Cash & Current Investments fell 66.85% year-over-year to $8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (down 66.85% YoY) and the FY2025 annual result came in at $13.0 million, down 30.28% from the prior year.
• Cash & Current Investments declined to $8.2 million in Q1 2026, from $13.0 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $48.1 million in Q1 2022 to a low of $8.2 million in Q1 2026.
• A 5-year average of $23.8 million and a median of $19.6 million in 2024 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments surged 66.12% — and 2026, when it slumped 66.85%.
• Tracing CALC's Cash & Current Investments over 5 years: stood at $33.6 million in 2022, then plunged by 66.51% to $11.2 million in 2023, then surged by 66.12% to $18.7 million in 2024, then sank by 30.28% to $13.0 million in 2025, then sank by 37.28% to $8.2 million in 2026.
• The last three Cash & Current Investments figures came in at $8.2 million (Q1 2026), $13.0 million (Q4 2025), and $14.1 million (Q3 2025), per Business Quant data.